News
-
-
-
COMMUNIQUÉ DE PRESSE
Sandoz announces partnership agreement with Samsung Bioepis on up to five biosimilars, further expanding its leading pipeline to up to 32 assets
Sandoz partners with Samsung Bioepis on up to five biosimilars, expanding its pipeline to 32 assets. The agreement aims to broaden patient access to high-quality medicines worldwide -
-
-
COMMUNIQUÉ DE PRESSE
Sandoz issues CHF 550 million in bonds and extends its USD 2 billion revolving credit facility by one year
Sandoz Group AG issues CHF 550 million in bonds & extends USD 2 billion revolving credit facility. Bonds for refinancing & general corporate purposes. Extension strengthens balance sheet -
-
-
COMMUNIQUÉ DE PRESSE
Sandoz creates new global biosimilar development, manufacturing and supply unit, appoints industry veteran Armin Metzger to lead next phase of growth
Sandoz creates new global biosimilar development, manufacturing, and supply unit with appointment of industry veteran Armin Metzger to lead growth strategy -
